Measuring treatment response to advance precision medicine for multiple sclerosis

MLA

Peter A. Calabresi, et al. “Measuring Treatment Response to Advance Precision Medicine for Multiple Sclerosis.” Annals of Clinical and Translational Neurology, vol. 8, no. 11, Nov. 2021, pp. 2166–73. EBSCOhost, https://doi.org/10.1002/acn3.51471.

APA

Peter A. Calabresi, Ludwig Kappos, Gavin Giovannoni, Tatiana Plavina, Irene Koulinska, Michael R. Edwards, Bernd Kieseier, Carl deMoor, Elias S. Sotirchos, Elizabeth Fisher, Richard A. Rudick, & Alfred Sandrock. (2021). Measuring treatment response to advance precision medicine for multiple sclerosis. Annals of Clinical and Translational Neurology, 8(11), 2166–2173. https://doi.org/10.1002/acn3.51471

Chicago

Peter A. Calabresi, Ludwig Kappos, Gavin Giovannoni, Tatiana Plavina, Irene Koulinska, Michael R. Edwards, Bernd Kieseier, et al. 2021. “Measuring Treatment Response to Advance Precision Medicine for Multiple Sclerosis.” Annals of Clinical and Translational Neurology 8 (11): 2166–73. doi:10.1002/acn3.51471.